CBIO vs PULM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

CBIO

58.4
AI Score
VS
CBIO Wins

PULM

38.5
AI Score

Investment Advisor Scores

CBIO

58score
Recommendation
HOLD

PULM

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric CBIO PULM Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% -99.9% CBIO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 58.4/100 38.5/100 CBIO
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY CBIO

Relative Price Performance (Last 90 Days)

CBIO 1M: -22.8% · 3M: -15.6% PULM 1M: +6.8% · 3M: -8.7%

Current Technical Phase

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 35.6 · Price: $14.32

PULM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.2 · Price: $1.57

Fundamentals Snapshot

Metric CBIO PULM
Market Cap — —
Forward P/E -5.4 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -1.0%
Gross Margin 1.0% -12.7%
Operating Margin -14.3% 0.0%
EPS -0.14 -1.10
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.